Insilico Medicine Appoints Michael Bayewitch as VP, Business Development and Strategy
May 15, 2023 13:34 ET
|
InSilico Medicine
Abu Dhabi, May 15, 2023 (GLOBE NEWSWIRE) -- Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, has appointed Michael Bayewitch, PhD, as Vice...
Insilico Medicine Appoints Michael Bayewitch as VP, Business Development and Strategy
May 15, 2023 13:20 ET
|
InSilico Medicine
Hong Kong, May 15, 2023 (GLOBE NEWSWIRE) -- Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, has appointed Michael Bayewitch, PhD, as Vice...
Insilico Medicine Appoints Michael Bayewitch as VP, Business Development and Strategy
May 15, 2023 12:45 ET
|
InSilico Medicine
New York, May 15, 2023 (GLOBE NEWSWIRE) -- Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, has appointed Michael Bayewitch, PhD, as Vice...
Insilico Medicine Founder and CEO to Give Keynote on Disease Modeling with AI at PEGS Boston
May 12, 2023 16:39 ET
|
InSilico Medicine
Abu Dhabi, May 12, 2023 (GLOBE NEWSWIRE) -- Insilico Medicine, a generative artificial intelligence (AI)-driven drug discovery company, announced that Alex Zhavoronkov, PhD, founder and CEO of the...
UAE Biotech Insilico Medicine Offers Disease Modeling and Target Identification Course Using AI
May 12, 2023 08:40 ET
|
InSilico Medicine
Abu Dhabi, May 12, 2023 (GLOBE NEWSWIRE) -- Insilico Medicine, a generative artificial intelligence (AI)-driven drug discovery company, announced that it is releasing a course on Disease Modeling...
AI Drug Discovery Company Insilico Medicine Offers Free Course on Target Identification
May 10, 2023 09:00 ET
|
InSilico Medicine
New York, May 10, 2023 (GLOBE NEWSWIRE) -- Insilico Medicine, a generative artificial intelligence (AI)-driven drug discovery company, announced today that it is releasing a course on Disease...
Head of Insilico Medicine’s Hong Kong R&D Center to Give Keynote on AI Drug Discovery at HKUST Big Data Institute
May 04, 2023 14:03 ET
|
InSilico Medicine
Hong Kong, May 04, 2023 (GLOBE NEWSWIRE) -- Frank Pun, PhD, Head of the Hong Kong R&D Center of Insilico Medicine (“Insilico”), a generative artificial intelligence (AI)-driven drug discovery...
Student Researchers Use UAE-Developed Generative AI Technology to Find New Brain Tumor Drug Targets
May 02, 2023 09:00 ET
|
InSilico Medicine
Abu Dhabi, May 02, 2023 (GLOBE NEWSWIRE) -- Three high school students – Andrea Olsen from Oslo, Norway; Zachary Harpaz from Boca Raton, Florida; and Chris Ren from Shanghai, China – co-authored a...
High School Student Researchers Find New Brain Tumor Drug Targets Using AI
May 02, 2023 09:00 ET
|
InSilico Medicine
New York, May 02, 2023 (GLOBE NEWSWIRE) -- Three high school students – Andrea Olsen from Oslo, Norway; Zachary Harpaz from Boca Raton, Florida; and Chris Ren from Shanghai, China – co-authored a...
Insilico Medicine Successfully Discovered Potent, Selective, and Orally Bioavailable Small Molecule Inhibitor of CDK8 Using Generative AI
April 24, 2023 15:14 ET
|
InSilico Medicine
Abu Dhabi, April 24, 2023 (GLOBE NEWSWIRE) -- Insilico Medicine (“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company which operates the largest...